Loading clinical trials...
Loading clinical trials...
Multi-provincial Cohort for Hypertension in China
The purpose of this study is to construct hypertension specialized cohort using uniform standards and specifications. This study timely collected multi-dimensional clinical information through electronic medical records, mobile health, data integration, informatics and computer modern techniques, linking self-reported data and big data platforms from different sources to timely obtain the incidence and mortality data, and integrating hypertension cohort samples and the associated clinical records systematically, in order to build a 30-thousand hypertension specialized cohort with fine phenotypic data and blood/urine samples, thus far to provide support for the development of precise medicine research and related industries.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Beijing Anzhen Hospital
Beijing, China
Beijing Tiantan Hospital
Beijing, China
Beijing Tsinghua Chang Gung Hospital
Beijing, China
Southwest Hospital, China
Chongqing, China
Nanfang Hospital of Southern Medical University
Guangzhou, China
Ruijin Hospital
Shanghai, China
Start Date
July 3, 2017
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
January 22, 2020
30,000
ESTIMATED participants
Antihypertensive Agents
DRUG
Cardiovascular risk factors
OTHER
Lead Sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions